Grampp G E, Applegate M A, Stephanopoulos G
Department of Chemical Engineering and Biotechnology Process Engineering Center, Massachusetts Institute of Technology, Cambridge 02139, USA.
Biotechnol Prog. 1996 Nov-Dec;12(6):837-46. doi: 10.1021/bp960066r.
Controlled secretion processes for the production of secretory proteins in monolayer culture have been described previously (Grampp et al. Adv. Biochem. Eng./ Biotechnol. 1992, 46, 35-62), but little is known about the feasibility of scaling such processes into high-density bioreactors. Two immobilized-cell, ceramic-matrix bioreactor configurations were tested using the beta TC-3 cell model system which, in monolayer culture, can be manipulated to secrete murine insulin in a highly controlled manner. One reactor was configured with an external recirculation reservoir for oxygen transfer and was operated as a conventional immobilized bed/recycle reactor. The other reactor was configured as a single-pass perfusion system with oxygen supplied by diffusion from silicone tubing positioned proximal to the porous walls of the ceramic matrix. After inoculation with beta TC-3 cells, both systems were perfused with serum-supplemented medium to stimulate cell growth, and they ultimately attained high densities (approximately 5 x 10(8) cells/mL of pore volume). To initiate controlled secretion operations, the reactor cores were washed with a serum-free basal medium, then exposed to a serum-free discharging medium containing secretory stimulants. Following several hours of discharging, the reactors were washed again, then switched to a serum-containing medium designed to quench the regulated secretion process. For the single-pass reactor these cycling operations were simple to implement and were effective in promoting the cyclic discharge and recharge of murine insulin. Because of the ability to reduce the perfusion rate in the single-pass reactor independent of oxygen transfer, the discharged insulin was captured in a relatively small volume (2 reactor core hold-up volumes), yielding a mean product concentration 10-fold greater than in the steady-state perfusate. Cyclic operation of the recirculating reactor was more difficult due to the complexity of switching between recirculation reservoirs, and the introduction of air bubbles during such operations resulted in the loss of biomass from the reactor after one cycle. Even in the first discharging cycle, the insulin yield was much lower than in the perfusate from the single-pass reactor, despite the comparable metabolic rates. The single-pass reactor was cycled successfully through four discharging and recharging episodes and maintained its ability to discharge insulin, albeit at a slower rate after the first discharge. Overall, 50-60% of the insulin secreted during the 48 h cycles was recovered during the brief discharging episodes. When insulin secretion rates and discharging yields were normalized to metabolic activity, neither high-density reactor system performed as well as did identically treated control T-flask cultures. It is hypothesized that the productivity and responsiveness of the high-density, pore-immobilized beta TC-3 cells are lower than in monolayer culture.
此前已有文献描述了在单层培养中生产分泌蛋白的可控分泌过程(Grampp等人,《Adv. Biochem. Eng./ Biotechnol.》,1992年,第46卷,第35 - 62页),但对于将此类过程扩大规模至高密度生物反应器的可行性却知之甚少。使用βTC - 3细胞模型系统对两种固定化细胞的陶瓷基质生物反应器配置进行了测试,在单层培养中,该细胞模型系统可被操控以高度可控的方式分泌小鼠胰岛素。一种反应器配置了用于氧气传递的外部循环储液器,并作为传统的固定床/循环反应器运行。另一种反应器配置为单通道灌注系统,通过位于陶瓷基质多孔壁附近的硅胶管扩散供氧。接种βTC - 3细胞后,两个系统均用补充血清的培养基灌注以刺激细胞生长,最终达到了高密度(每孔体积约5×10⁸个细胞/mL)。为启动可控分泌操作,先用无血清基础培养基冲洗反应器核心,然后将其暴露于含有分泌刺激剂的无血清排放培养基中。排放数小时后,再次冲洗反应器,然后切换至旨在终止调节分泌过程的含血清培养基。对于单通道反应器,这些循环操作易于实施,并且有效地促进了小鼠胰岛素的循环排放和补充。由于能够独立于氧气传递降低单通道反应器中的灌注速率,排放的胰岛素在相对较小的体积(2个反应器核心滞留体积)中被捕获,平均产物浓度比稳态灌注液高10倍。循环反应器的循环操作更为困难,这是由于在循环储液器之间切换的复杂性,并且在此类操作过程中引入气泡导致一个循环后反应器中的生物质损失。即使在第一个排放循环中,尽管代谢速率相当,但胰岛素产量仍远低于单通道反应器灌注液中的产量。单通道反应器成功地循环进行了四次排放和补充过程,并保持了其排放胰岛素的能力,尽管在第一次排放后速率较慢。总体而言,在48小时循环期间分泌的胰岛素中有50 - 60%在短暂的排放过程中被回收。当将胰岛素分泌速率和排放产量归一化为代谢活性时,两个高密度反应器系统的表现均不如经过相同处理的对照T型瓶培养物。据推测,高密度、孔固定化的βTC - 3细胞的生产力和反应性低于单层培养中的细胞。